Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.
about
Surgical ablation for atrial fibrillationSurgical ablation for atrial fibrillationThe effect of ethnicity on outcomes in a practice-based trial to improve cardiovascular disease preventionAnticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatranIncreased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution.Postoperative atrial fibrillation in patients undergoing non-cardiac non-thoracic surgery: A practical approach for the hospitalistDirect thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillationUsing a summary measure for multiple quality indicators in primary care: the Summary QUality InDex (SQUID)Blood stasis may cause thrombosis in the left superior pulmonary vein stump after left upper lobectomy.Laser ablation of the pulmonary veins by using a fiberoptic balloon catheter: implications for treatment of paroxysmal atrial fibrillation.Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: results of long-term follow-up.Hypoxic hepatitis and acute liver failure in a patient with newly onset atrial fibrillation and diltiazem infusionAnticoagulant therapy, anti-platelet agents and gastrointestinal endoscopy.Atrial fibrillation: prevalence and management in an acute general medical unit.Optimal management of the patient with an episode of atrial fibrillation in and out of the hospital: acute cardioversion or not?Management of intermittent atrial fibrillation: drugs to maintain sinus rhythm.The case for inpatient initiation of antiarrhythmic therapy.Oral anticoagulation in nonvalvular atrial fibrillation.Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.New challenges of geriatric cardiology: from clinical to preclinical researchUpdate on Atrial Fibrillation: Restoration of Sinus Rhythm or Ventricular Rate Control?Pharmacological management of atrial fibrillation: an update.Determination of the target ventricular rate in patients with atrial fibrillation by evaluation of ventriculoarterial coupling.Therapy of atrial fibrillation: rhythm control versus rate control.Risk of thromboembolism in acute atrial fibrillation or atrial flutter.Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.Dofetilide: a new class III antiarrhythmic for the management of atrial fibrillation.Importance of QT interval determination and renal function assessment during antiarrhythmic drug therapy.Atrial fibrillation in the elderly--an increasing problem that mandates aggressive management.Gastroesophageal reflux disease and atrial fibrillation: a nationwide population-based study.Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.Long-term pharmacologic management of atrial fibrillation in the elderly.Physician compliance with outpatient oral anticoagulant guidelines in Auvergne, France.Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm.Anticoagulants for atrial fibrillation: why is the treatment rate so low?Emergency management of atrial fibrillationLow dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled studyPreload-adjusted maximal power: a novel index of left ventricular contractility in atrial fibrillation.Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillationPrevention of venous thromboembolism after stroke.
P2860
Q24200933-1BDECED4-CC37-4536-BFD1-9056133F1540Q24240407-3A64AB93-C965-4E45-BAEA-B7275F2C3312Q24800136-40076DB8-3218-4E29-AA90-B808D5808D82Q24807132-701B52DA-0014-4B80-8BD5-2E25802D6FB9Q25256818-E04E4BC6-30CC-4A46-A95A-69622E706C13Q26785568-C20A14D2-B6B9-45FC-8C26-7CF1722FF69FQ28176666-E8A864F2-D75B-4171-9F75-60F1942B2F40Q28222052-BAFB40C4-8C18-4D6B-98C6-62D1D6362357Q30588268-16CC3C60-F1BE-417A-9058-9E1301611759Q30663566-4F535731-8F1F-4685-986E-AEA0642EE784Q33148835-CDC28F2E-B9FF-413B-9C28-1566D95EBEA7Q33410368-D6E1944F-33D1-42D1-9C39-16765346DBD8Q33535684-8B405BAA-5A53-4009-90A5-E031731776FEQ33592414-D52D95A5-7110-4FB9-967B-6EE21327E757Q33597985-9FA84FE7-740A-425B-A227-D3F31EDBD577Q33597990-87B8523D-BFE6-4332-9E06-9526B75BF29DQ33598024-78E4C9B0-7EAB-48A9-B95A-66481A291052Q33651503-3187B11C-C382-417E-BAD4-8042EA572391Q33815844-1CF40963-8DC2-4F63-94FA-74612CF7E267Q33831628-B1BF18D9-D58B-45A9-AD87-49A851365E78Q33843408-C8BCA55E-28B0-472F-8922-58AF1FD7F618Q33845159-CC557801-4E6A-4A5B-B060-BF1642519300Q33881058-E91772D2-67EF-485C-A714-3072FC8C86D6Q33931009-E895F908-457B-4307-9990-0CD93E66173CQ34026450-37D1741C-7A85-4465-90F1-2C98D8DC52CEQ34113373-5B1548FB-2FBC-4DBE-8051-35345D80B937Q34314202-2519F3C2-1099-4FAA-815C-D7190A279E4EQ34339685-B26D621B-6BAC-4AA6-B0AC-280610A6217CQ34350281-4E1486AC-6C06-4E37-9808-DAD60A474084Q34450967-D5344A54-97E4-4E9E-A11F-1744E00AD9DFQ34491925-B83718B3-B5B1-4D9A-8AC7-1195FEF94DF9Q34714759-C01CCCE3-F303-45DE-A31D-DEB3D7770DCEQ34742633-5DE704A7-CE02-4F19-8861-508D44C22D1DQ34778146-B32C2C10-BA56-404B-BC8F-43EFF3251CF2Q34958223-58A712AE-E50C-4E9A-873F-D238C75F1E24Q35168643-D3A50E92-D633-45EC-8CC2-5F85AF0958FDQ35567061-B9D44B2E-F6DD-4726-9CA7-7FD8822B7682Q35580186-D1A40FCB-D83E-4396-AFED-ED566C605AB4Q35582996-4DBCCA3D-0B25-4366-9C17-D98EBFEAB054Q35610118-D0C91E1C-CEE4-48D2-8C04-F087EF542413
P2860
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Management of patients with at ...... y, American Heart Association.
@en
type
label
Management of patients with at ...... y, American Heart Association.
@en
prefLabel
Management of patients with at ...... y, American Heart Association.
@en
P2093
P921
P356
P1433
P1476
Management of patients with at ...... y, American Heart Association.
@en
P2093
Benson DW Jr
Myerburg RJ
Naccarelli GV
Prystowsky EN
P304
P356
10.1161/01.CIR.93.6.1262
P407
P577
1996-03-01T00:00:00Z